; Włodarski, Marcin W ; Raj, Kavita ; Onida, Francesco ; Worel, Nina ; Ciceri, Fabio ; Carbacioglu, Selim ; Kenyon, Michelle ; Aljurf, Mahmoud ; Bonfim, Carmem ; Makishima, Hideki ; Niemeyer, Charlotte ; Fenaux, Pierre ; Zebisch, Armin ; Hamad, Nada
; Chalandon, Yves ; Hellström-Lindberg, Eva ; Voso, Maria Teresa ; Mecucci, Cristina ; Duarte, Fernando Barroso ; Sebert, Marie ; Sicre de Fontbrune, Flore ; Soulier, Jean ; Shimamura, Akiko ; Lindsley, R Coleman ; Maciejewski, Jarosław P ; Calado, Rodrigo T
; Yakoub-Agha, Ibrahim ; McLornan, Donal P | Item type: | Article | ||||
|---|---|---|---|---|---|
| Journal or Publication Title: | The Lancet Haematology | ||||
| Publisher: | ELSEVIER SCI LTD | ||||
| Place of Publication: | London | ||||
| Volume: | 10 | ||||
| Number of Issue or Book Chapter: | 12 | ||||
| Page Range: | e994-e1005 | ||||
| Date: | 2023 | ||||
| Institutions: | Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation | ||||
| Identification Number: |
| ||||
| Keywords: | BONE-MARROW FAILURE; ACUTE MYELOID-LEUKEMIA; FANCONI-ANEMIA; CONDITIONING REGIMEN; CHILDREN; VARIANTS; BLOOD; CLASSIFICATION; COMPLICATIONS; GUIDELINES | ||||
| Dewey Decimal Classification: | 600 Technology > 610 Medical sciences Medicine | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Item ID: | 76312 |
Abstract
The recent application of whole exome or whole genome sequencing unveiled a plethora of germline variants predisposing to myeloid disorders, particularly myelodysplastic neoplasms. The presence of such variants in patients with myelodysplastic syndromes has important clinical repercussions for haematopoietic stem-cell transplantation, from donor selection and conditioning regimen to ...

Abstract
The recent application of whole exome or whole genome sequencing unveiled a plethora of germline variants predisposing to myeloid disorders, particularly myelodysplastic neoplasms. The presence of such variants in patients with myelodysplastic syndromes has important clinical repercussions for haematopoietic stem-cell transplantation, from donor selection and conditioning regimen to graft-versus-host disease prophylaxis and genetic counselling for relatives. No international guidelines exist to harmonise management approaches to this particular clinical scenario. Moreover, the application of germline testing, and how this informs clinical decisions, differs according to the expertise of individual clinical practices and according to different countries, health-care systems, and legislations. Leveraging the global span of the European Society for Blood and Marrow Transplantation (EBMT) network, we took a snapshot of the current European situation on these matters by disseminating an electronic survey to EBMT centres experienced in myelodysplastic syndromes transplantation. An international group of haematologists, transplantation physicians, paediatricians, nurses, and experts in molecular biology and constitutional genetics with experience in myelodysplastic syndromes contributed to this Position Paper. The panel met during multiple online meetings to discuss the results of the EBMT survey and to establish suggested harmonised guidelines for such clinical situations, which are presented here.
Metadata last modified: 18 Mar 2025 10:11
Altmetric